Researchers at Ohio State University have pinpointed a human gene product that helps to regulate wound healing and may control scarring in people recovering from severe injuries and damage to certain internal organs.
The protein, MG53, travels throughout the bloodstream and helps the body fix injuries to the skin, heart, lungs, kidneys and other organs without causing scars. It's a discovery that could help heal open wounds, decrease recovery time after surgery and reduce the spread of infections.
"A massive scar on your skin may look bad, but imagine you have a heart attack and get a scar on your heart-that could be lethal," says Jianjie Ma, a physiologist at Ohio State and co-author of the presentation.
All animals carry this gene, he said, and it's almost identical no matter which species. MG53 fixes the cell and tissue damage that occurs during everyday living. Even simple actions, like walking or typing, will cause injuries to the body. Usually this isn't a problem because MG53 can make repairs before there's any serious harm.
Ma and his team genetically engineered mice without the gene that makes MG53 to see what would happen without its healing capabilities. The experiments showed that the mice lacking MG53 had difficulty recovering from injury, because of their compromised repair capacity; their heart would not function well under stress conditions.
MG53 works in tandem with another protein called TGF Beta, a type of "cytokine" protein that also heals wounds, but the healing process happens so quickly that it causes scars. If you have more TGF Beta in your bloodstream than MG53, you scar easily.
Ma's goal is to develop a therapy that will inhibit TGF Beta and promote MG53. Medical professionals can use the therapy during procedures to promote quick, scarless healing. His next step is to identify a small compound that can do this and eventually test whether it has the desired effect in human trials.
Source: Biophysical Society
Comprehensive Guide to Lymphedema: Causes, Prevention, and Management Strategies
May 3rd 2024Lymphedema, a chronic condition often stemming from cancer treatments, leads to tissue swelling. Early detection through surveillance programs and proper skincare can prevent complications like infections.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses (AORN) Global Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
Weekly Rounds: Four Years of COVID-19, AORN 2024 Conference Coverage, and More
March 18th 2024Here are 5 highlights from Infection Control Today®'s (ICT®’s) wide-ranging coverage of the infection prevention and control world. Everything from interviews with known opinion leaders to the news that infection preventionists and other health care professionals can use on their jobs.